ADPT Adaptive Biotechnologies Corporation

NAS · US · Healthcare · Diagnostics & Research · adaptivebiotech.com

26.90USD-9.85%Mkt Cap: 4.29B $P/E: —1d ago

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a su…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

IDEXX Laboratories, Inc.

$40.66BUSDP/E 36.2

MTD

Mettler-Toledo International Inc.

$30.72BUSDP/E 34.6

Labcorp Holdings Inc.

$25.28BUSDP/E 25.8

DGX

Quest Diagnostics Incorporated

$25.21BUSDP/E 24.2

Guardant Health, Inc.

Medpace Holdings, Inc.

$16.83BUSDP/E 35.4

ERF

Eurofins Scientific SE

$14.16BUSDP/E 26.4

CRL

Charles River Laboratories International, Inc.

$14.56BUSD

ICLR

ICON Public Limited Company

Key Statistics

Company

Market Cap4.29B USD

Enterprise Value4.60B USD

Revenue (TTM)308.08M USD

Gross Profit205.62M USD

Net Income (TTM)-59.50M USD

Revenue/Share1.98 USD

Last Price26.90 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees624

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-157.11

PEG—

EV/EBITDA-215.62

EV/Revenue14.93

P/S14.69

P/B31.57

EPS (TTM)-0.41

EPS (Forward)-0.18

52W Range

12.0080% of range30.74

52W High30.74 USD

52W Low12.00 USD

Profitability

Gross Margin74.24%

Oper. Margin-22.04%

EBITDA Margin-6.92%

Profit Margin-21.48%

ROE-27.19%

ROA-11.60%

Growth

Revenue Growth21.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-45.99M USD

CapEx (TTM)2.96M USD

FCF Margin6.16%

FCF Yield0.44%

Net Debt66.24M USD

Net Debt/EBITDA-3.11

Balance Sheet

Debt/Equity0.36

Current Ratio4.79

Quick Ratio4.51

Book Value/Sh0.90 USD

Cash/Share2.16 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.4 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)28.31 USD

Upside (mean)+5.3%

Target Range21.00 USD – 35.00 USD

21.00+5.3% to mean35.00

# Analysts8

Ownership

Shares Out.159.60M

Float125.48M

Insiders1.29%

Institutions99.51%

Short Interest

Short Ratio7.5d

Short % Float10.68%

Short % Out.8.45%

Shares Short13.49M

Short (prev mo.)13.32M

Technical

SMA 5025.59 (+5.1%)

SMA 20018.66 (+44.2%)

Beta2.10

S&P 52W Chg14.58%

Avg Vol (30d)2.10M

Avg Vol (10d)2.61M

Technical Indicators

RSI (14)50.1

MACD1.0429

MACD Signal1.1620

MACD Hist.-0.1192

BB Upper31.20 USD

BB Middle27.15 USD

BB Lower23.10 USD

BB Width29.86%

ATR (14)1.535 USD

Vol Ratio (20d)1.14x